Mode
Text Size
Log in / Sign up

t-FAMMIF flaps showed superior aesthetic and sensory outcomes versus cutaneous flaps in oral cancer reconstruction.

t-FAMMIF flaps showed superior aesthetic and sensory outcomes versus cutaneous flaps in oral cancer …
Photo by Navy Medicine / Unsplash
Key Takeaway
Consider t-FAMMIF for small to moderate mucosal defects, noting superior early outcomes in this small cohort.

This cohort study assessed the clinical efficacy of tunnelized-facial artery myomucosal island flaps (t-FAMMIF) for reconstructing mucosal defects following oral cancer surgery. The population comprised 23 patients who underwent t-FAMMIF reconstruction and 20 cases in the t-FAMMIF group paired with 20 cases in the cutaneous flap group. The setting involved oral cavity reconstruction, with a follow-up period of six months. Secondary outcomes included functional recovery, complication resolution, aesthetic outcomes, sensory outcomes, facial nerve dysfunction, trismus, scar formation, and salivary gland preservation.

At six months, aesthetic and sensory outcomes were superior in the t-FAMMIF group compared to the cutaneous flap group. Facial nerve dysfunction and trismus were largely resolved by the six-month mark in both groups. Histological analysis conducted in an animal model indicated that mucosal flaps preserved minor salivary glands and exhibited significantly reduced scar formation compared to cutaneous flaps. No adverse events, serious adverse events, discontinuations, or specific tolerability data were reported in the clinical cohort.

Key limitations include the small sample size, the absence of statistical measures such as p-values or confidence intervals, and the reliance on an animal model for some findings. The study phase and publication type were not reported. Funding or conflicts of interest were not reported. While the practice relevance suggests t-FAMMIF is an effective option for reconstructing small to moderate mucosal defects, the observational nature of the evidence and incomplete data prevent definitive causal conclusions regarding long-term benefits or safety profiles.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
This study aims to evaluate the clinical efficacy of tunnelized-facial artery myomucosal island flaps (t-FAMMIF) in reconstructing mucosal defects following oral cancer surgery and compare the characteristics between mucosal and cutaneous flaps. A total of 23 patients who underwent t-FAMMIF reconstruction were enrolled and monitored for functional recovery and complication resolution. Using propensity score matching, 20 cases were paired with a cohort of patients receiving cutaneous flaps (n=20 per group). Sensory function was assessed using the Semmes-Weinstein monofilament test and two-point discrimination tests, while motor function was evaluated with the Water Swallowing Test. Facial nerve function was assessed by House-Brackmann grading scale, wireless surface electromyography, and FaceGram software. Mouth opening was measured by maximum inter-incisal opening. Additionally, to explore the mechanisms underlying differential functional recovery, mucosal and cutaneous flaps were compared in a beagle dog model, with subsequent histological analysis. Compared to the cutaneous flap group, the t-FAMMIF group exhibited superior aesthetic and sensory outcomes, with facial nerve dysfunction and trismus largely resolved by 6 months. Histological analysis in the animal model revealed that mucosal flaps preserved minor salivary glands and exhibited significantly reduced scar formation, providing a tissue-level explanation for the enhanced sensory recovery observed clinically. T-FAMMIF is an effective option for reconstructing small to moderate mucosal defects. Compared to cutaneous flaps, it provides advantages including superior aesthetic results, enhanced sensory recovery, minimized scarring, and preservation of salivary gland function.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.